Brca2 C-terminus interacts with Rad51 and contributes to nuclear focus formation in double-strand break repair of DNA

Biomedical Research

Volumn 25, Issue 6, 2004, Pages 269-275

  Ochiai, Kazuhiko ^a   Morimatsu, Masami ^b,c   Yoshikawa, Yasunaga ^b   Syuto, Bunei ^b   Hashizume, Kazuyoshi ^b  

^a GIFU UNIVERSITY   (Japan)

^b IWATE UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; DOUBLE STRANDED DNA; RAD51 PROTEIN;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CELL STRAIN COS7; CONTROLLED STUDY; DNA REPAIR; DOG; HUMAN; HUMAN CELL; IN VIVO STUDY; IONIZING RADIATION; MAMMAL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TWO HYBRID SYSTEM; YEAST;

ANIMALIA; CANIS FAMILIARIS; MAMMALIA; MURINAE;

EID: 27244456612     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.25.269     Document Type: Article

References (26)

1. Chen JJ, Silver D, Cantor S, Livingston DM and Scully R (1999) BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway. Cancer Res 59, 1752-1756
2. Chen PL, Chen CF, Chen Y, Xiao J, Sharp ZA and Lee WH (1998) The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment. Proc Natl Acad Sci USA 95, 5287-5292.
3. Davis KK, Masson, J.Y., McILwraith MJ, Stasiak AZ, Stasiak A. Venkitaraman AR and West SC (2001) Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Mol Cell 7, 273-282
4. Donoho G, Brenneman MA, Cui TX, Donoviel D, Vogel H, Goodwin DJ, Chen EH and Hasty P (2003) Deletion of Brca2 exon 27 causes, hypersensitivity to DNA crosslinks, chromosomal instability and reduced life span in mice. Genes Chromosomes Cancer 36, 317-331.
5. Dorn CR, Taylor DO, Frye FL and Hibbard HH (1968) Survey of animal neoplasms in Alameda and Contra Costa Counties, California. 1. Methodology and description of cases. J Natl Cancer Inst 40, 295-305.
6. Fidler IJ and Brodey RS (1%7) A necropsy study of canine malignant mammary neoplasms. J Am Vet Med Assoc 151, 710-715.
7. Garvin AM, Attenhofer-Haner M and Scott RJ (1997) BRCAI and BRCA2 mutation analysis in 86 early onset breast/ovarian cancer patients. J Med Genet 34, 990-995.
8. Marmorstein LY, Ouchi T and Aaronson SA (1998) The BRCA2 gene product functionally interacts with p53 and RAD51. Proc Natl Acad Sci USA 95, 13869-13874.
9. McAllister KA, Bennett LM, Houle CD, Ward T, Malphurs J, Collins NY, Cachafeiro C, Haseman J, Goulding EH, Bunch D, Eddy EM, Davis BJ and Wiseman RW (2002) Cancer susceptibility of mice with a homozygous deletion in the COOH-terminal domain of the Brca2 gene. Cancer Res 62, 990-094.
10. Morimatsu M, Donoho G and Hasty P (1998) Cells deleted for Brca2 COOH terminus exhibit hypersensitivity to gamma-radiation and premature senescence. Cancer Res 58, 3441-3447.
11. Moulton JE, Taylor DO, Dorn CR and Andersen AC (1970) Canine mammary tumors. Pathol Vet 7, 289-320.
12. Ochiai K, Morimatsu M, Tomizawa N and Syuto B (2001) Cloning and sequencing full length of canine Brca2 and Rad51 cDNA. J Vet Med Sci 63, 1103-1108.
13. Ogawa T, Yu X, Shinohara A and Egelman EH (1993) Similarity of the yeast RAD51 filament to the bacterial RecA filament Science 259, 1896-1899.
14. Priester WA and Mantel N (1971) Occurrence of tumors in domestic animals. Data from 12 United States and Canadian colleges of veterinary medicine. J Natl Cancer Inst 47, 1333-1344.
15. Rutteman GR, Cornelisse CJ, Dijkshoorn NJ, Poortman J and Misdorp W (1988) Flow cytometric analysis of DNA ploidy in canine mammary tumors. Cancer Res 48, 3411-3417.
16. Sharan SK, Morimatsu M, Albrecht U. Lim DS, Regel E, Dinh C, Sands A, Eichele G, Hasty P and Bradley A (1997) Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386, 804-810.
17. Tap OT, Rutteman GR, Zijlstra C, Haan NA and Bosma AA (1998) Analysis of chromosome aberrations in mammary carcinoma cell line from a dog by using canine painting probes. Cytogenet Cell Genet 82, 75-79.
18. Tarsounas M, Davies D and West SC (2003) BRCA2-dependent and independent formation of RAD51 nuclear foci. Oncogene 22, 1115-1123.
19. Taylor GN, Shabestari L, Williams J, Mays CW, Angus W and McFarland S (1976) Mammary neoplasia in a closed beagle colony. Cancer Res 36, 2740-2743.
20. Tutt A, Bertwistle D, Valentine J, Gabriel A, Swift S, Ross G, Griffin C, Thacker and Ashworth A (2001) Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences. Embo J 20, 4704-4716
21. Warren M, Lord CJ, Masabanda J, Griffin D and Ashworth A (2003) Phenotypic effects of heterozygosity for a BRCA2 mutation. Hum Mol Genet 12, 2645-2656.
22. Wong AK, Pero R, Ormonde PA, Tavtigian SV and Bartel PL (1997) RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2. J Biol Chem 272, 31941-31944.
23. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D. Collins N, Nguyen K, Seal S, Tran T, Averill D and et al. (1994) Localization of a breast cancer susceptibility gene BRCA2, to chromosome 13q12-13. Science 265, 2088-2090.
24. Xia F, Taghian DG, DeFrank JS, Zeng ZC, Willers H, Iliakis G and Powell SN (2001) Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining. Proc Natl Acad Sci USA 98, 8644-8649.
25. Yano K, Morotomi K, Saito H, Kato M, Matsuo F and Miki Y (2000) Nuclear localization signals of the BRCA2 protein Biochem Biophys Res Commun 270, 171-175.
26. Yuan SS, Lee SY, Chen G, Song M, Tomlinson GE ard Lee EY (1999) BRCA2 is required for ionizing radiation-induced assembly ot Rad51 complex in vivo. Cancer Res 59, 3547-3551.